Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 14, 2016; 22(34): 7760-7766
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7760
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7760
Table 1 Development of pancreatic stone formation and functional impairment in autoimmune pancreatitis patients during long-term follow-up
Ref. | Year | Follow-up period (mo) | Incident rate | ||
Pancreatic stone | Endocrine dysfunction | Endocrine dysfunction | |||
Uchida et al[15] | 2006 | 41 | 4.8% (1/21) | 60.0% (6/10) | 46.2% (6/13) |
Maire et al[23] | 2011 | 50 | NA | 34.1% (15/44) | 38.6% (17/44) |
Maruyama et al[14] | 2012 | 91 | 40.6% (28/69) | NA | NA |
Hart et al[12] | 2013 | NA | 7.0% (46/659) | NA | NA |
Hirano et al[13] | 2013 | 76 | 11.3% (8/71) | NA | NA |
Buijs et al[24] | 2015 | 75 | NA | 82.4% (56/68) | 56.1% (37/66) |
- Citation: Ikeura T, Miyoshi H, Shimatani M, Uchida K, Takaoka M, Okazaki K. Long-term outcomes of autoimmune pancreatitis. World J Gastroenterol 2016; 22(34): 7760-7766
- URL: https://www.wjgnet.com/1007-9327/full/v22/i34/7760.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i34.7760